1 / 11

Monitoring NRG Oncology Accrual Trends and Membership Engagement (July 2014)

This session focuses on the monitoring of enrollment trends within NRG Oncology from March to June 2014, featuring insights from esteemed experts such as Philip J. DiSaia, Walter J. Curran, and Mitch Machtay. Topics include identifying challenges faced by long-standing members, fostering healthy competition among participating institutions, and the ongoing development of trial protocols. The session highlights robust enrollment accomplishments, largely driven by established Phase III trials, and emphasizes the urgent need for new trials across all disease sites to enhance participation and research effectiveness.

solana
Télécharger la présentation

Monitoring NRG Oncology Accrual Trends and Membership Engagement (July 2014)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. NRG Oncology General Session Welcome Philip J. DiSaia, MD NRG Oncology Accrual Activity Walter J. Curran, MD Protocols in Development Mitch Machtay, MD Protocol Activations   J. Tate Thigpen, MD Membership & Grant Activity Larry Wickerham, MD July 12, 2014

  2. NRG Oncology Participation ActivityMarch 1 – June 30, 2014Walter J. Curran, Jr., M.D.Group Chair July 12, 2014

  3. NRG Oncology AccrualPurpose of this Discussion • Monitor Enrollment Trends & Opportunities • Identify Issues with Long Standing Members • Create Healthy Rivalries/Competition • Identity of NRG Oncology Membership

  4. NRG Accrual by Disease Site*(March – June 2014) *Includes DCP Trials

  5. NRG Accrual by Membership Category*(March – June 2014) *Includes Non-Companion DCP Trials

  6. NRG Top 10 Accruing LAPS Networks(March – June 2014)

  7. NRG Top 10 CCOP Networks(March – June 2014)

  8. NRG Top 10 Non- LAPS/CCOP Members (March – June 2014)

  9. Top 10 Accruing NRG Protocols(March – June 2014)

  10. NRG Oncology Main Member, LAPS, & CCOP Institutions June 2014

  11. Robust Enrollment for First Quarter • Enrollment Mainly to “Legacy” Phase III Trials • DCP Trial Enrollment Will Presented Separately • Will Monitor Enrollment to New NRG Trials • Need for New Trials across All Disease Sites • Such Reports will be on Website/Newsletters NRG Oncology Accrual: Summary

More Related